Bruton’s tyrosine kinase inhibitors in primary immune thrombocytopenia: pathophysiology and clinical evidence

Blood Vessels, Thrombosis & Hemostasis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles